2009: 102/2 (Aug) pp. 183-420

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

31 articles
1.
Genetic variants and risk for venous thromboembolic events: Summing up the evidence

Daniel Kurnik1,3; Aaron Lubetsky2,3

1Division of Clinical Pharmacology and Toxicology, and Department of Medicine A, Chaim Sheba Medical Center, Tel Hashomer, Israel; 2National Hemophilia Center and Institute of Thrombosis and Hemostasis, Department of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel; 3Sackler Faculty of Medicine, Tel Aviv University, Israel

Thrombosis and Haemostasis 2009 102 2: 183-184

http://dx.doi.org/10.1160/TH09-06-0350

[Summary] [Free download]
2.
The endothelium and thrombotic risk in heart failure

Eduard Shantsila; Gregory Y. H. Lip

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK

Thrombosis and Haemostasis 2009 102 2: 185-187

http://dx.doi.org/10.1160/TH09-06-0344

[Summary] [Free download]
3.
Frontiers of vascular biology: Mechanisms of inflammation and immunoregulation during arterial remodelling

Christian Weber

Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany

Thrombosis and Haemostasis 2009 102 2: 188-190

http://dx.doi.org/10.1160/TH09-06-0371

[Summary] [Free download]
4.
Novel aspects in the regulation of the leukocyte adhesion cascade

Emmanouil Chavakis1; Eun Young Choi2; Triantafyllos Chavakis2

1Institute of Cardiovascular Regeneration, Dept. of Internal Medicine III, J.W. Goethe University Frankfurt, Frankfurt, Germany; 2Experimental Immunology Branch, NCI, NIH, Bethesda, Maryland, USA

Thrombosis and Haemostasis 2009 102 2: 191-197

http://dx.doi.org/10.1160/TH08-12-0844

[Summary] [Free download]
5.
Neutrophils launch monocyte extravasation by release of granule proteins

Oliver Soehnlein; Alma Zernecke; Christian Weber

Institute for Molecular Cardiovascular Research (IMCAR), RWTH University Aachen, Germany

Thrombosis and Haemostasis 2009 102 2: 198-205

http://dx.doi.org/10.1160/TH08-11-0720

[Summary] [Free download]
6.
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis

Dirk Lievens1; Wouter J. Eijgelaar1; Erik A. L. Biessen1; Mat J. A. P. Daemen1; Esther Lutgens1,2

1Experimental Vascular Pathology Division (EVP), Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM) University of Maastricht, The Netherlands; 2Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany

Thrombosis and Haemostasis 2009 102 2: 206-214

http://dx.doi.org/10.1160/TH09-01-0029

[Summary] [Free download]
7.
How much is too much? Interleukin-6 and its signalling in atherosclerosis

Harald Schuett; Maren Luchtefeld; Christina Grothusen; Karsten Grote; Bernhard Schieffer

Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany

Thrombosis and Haemostasis 2009 102 2: 215-222

http://dx.doi.org/10.1160/TH09-05-0297

[Summary] [Free download]
8.
Effect of natural killer T cell activation on the initiation of atherosclerosis

Gijs H. M. van Puijvelde; Eva J. A. van Wanrooij; Arnaud D. Hauer; Paula de Vos; Theo J. C. van Berkel; Johan Kuiper

Division of Biopharmaceutics, LACDR/Leiden University, Leiden, the Netherlands

Thrombosis and Haemostasis 2009 102 2: 223-230

http://dx.doi.org/10.1160/TH09-01-0020

[Summary] [Free download]
9.
The vulnerable patient: Refocusing on the plaque?

Wouter J. Eijgelaar; Sylvia Heeneman; Mat J. A. P. Daemen

Experimental Vascular Pathology (EVP) Division, Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands

Thrombosis and Haemostasis 2009 102 2: 231-239

http://dx.doi.org/10.1160/TH09-01-0030

[Summary] [Free download]
10.
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury

Sabine Steffens*; Fabrizio Montecucco*; François Mach

Division of Cardiology, Foundation for Medical Researches, University Hospital, Geneva, Switzerland

Thrombosis and Haemostasis 2009 102 2: 240-247

http://dx.doi.org/10.1160/TH08-12-0837

[Summary] [Free download]
11.
Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis

Lisa K. Jennings

Vascular Biology Center of Excellence, University of Tennessee Health Science Center, Memphis, Tennessee, USA

Thrombosis and Haemostasis 2009 102 2: 248-257

http://dx.doi.org/10.1160/TH09-03-0192

[Summary] [Free download]
12.
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence

Shaker A. Mousa1; Lars J. Petersen2

1The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, New York, USA; 2Laboratory of Experimental Physiology & Inflammation, Department of Clinical Physiology, Viborg Hospital, Denmark

Thrombosis and Haemostasis 2009 102 2: 258-267

http://dx.doi.org/10.1160/TH08-12-0832

[Summary] [Free download]
13.
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

Gualtiero Palareti; Benilde Cosmi

Department of Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy

Thrombosis and Haemostasis 2009 102 2: 268-278

http://dx.doi.org/10.1160/TH08-11-0730

[Summary] [Free download]
14.
[Add to basket]
Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis

Victor Gurewich; Ralph Pannell

Vascular Research Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 2: 279-286

http://dx.doi.org/10.1160/TH08-09-0598

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency

Rebecca E. Saunders1; Nuha Shiltagh1; Keith Gomez2; Gillian Mellars2; Carolyn Cooper3; David J. Perry3; Edward G. Tuddenham2; Stephen J. Perkins1

1Institute of Structural and Molecular Biology, University College London, London, UK; 2Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, Pond Street, London, UK; 3Department of Haematology, Addenbrookes Hospital, Hills Road, Cambridge, UK

Thrombosis and Haemostasis 2009 102 2: 287-301

http://dx.doi.org/10.1160/TH09-01-0044

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model

Leslie R. Berry1,2; Bruce Thong1,2; Anthony K. C. Chan1,2

1Henderson Research Centre, Hamilton, Ontario, Canada; 2Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2009 102 2: 302-308

http://dx.doi.org/10.1160/TH09-01-0062

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications

Giovanni Tiscia1; Donatella Colaizzo1; Elena Chinni1; Daniela Pisanelli1; Natale Sciannamè2; Giovanni Favuzzi1; Maurizio Margaglione1,3; Elvira Grandone1

1Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S. Giovanni R. (FG), University of Foggia, Foggia, Italy; 2 Obstetrics and Gynaecology, I.R.C.C.S. Casa Sollievo della Sofferenza, S. Giovanni R. (FG), University of Foggia, Foggia, Italy; 3 Medical Genetics, University of Foggia, Foggia, Italy

Thrombosis and Haemostasis 2009 102 2: 309-313

http://dx.doi.org/10.1160/TH09-02-0123

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
Prognostic impact of haemostatic derangements in chronic heart failure

Borut Jug1; Nina Vene1; Barbara Gužic Salobir2; Miran Šebeštjen1; Mišo Šabovic1; Irena Keber1

1Department of Vascular Diseases, Clinic of Internal Medicine, University Clinical Center Ljubljana, Slovenia; 2Clinic of Nuclear Medicine, University Clinical Center Ljubljana, Slovenia

Thrombosis and Haemostasis 2009 102 2: 314-320

http://dx.doi.org/10.1160/TH08-11-0721

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis

Alpesh N. Amin1; Jay Lin2; Greg Lenhart3; Kathy L. Schulman3

1University of California – Irvine, Orange, California, USA; 2sanofi-aventis, Bridgewater, New Jersey, USA; 3Healthcare, Thomson Reuters, Cambridge, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 2: 321-326

http://dx.doi.org/10.1160/TH09-03-0147

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3β in platelets

- See additional contents by clicking on [Summary] -

Hideki Hayashi; Toshiki Sudo

First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan

Thrombosis and Haemostasis 2009 102 2: 327-335

http://dx.doi.org/10.1160/TH08-12-0781

[Summary] [PDF] [Pay per view]
  1-20 21-31
Next page

Articles

You've 591 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...